The Effects of Resistance Exercise and Protein Supplementation in Hemodialysis Patients

This study has been completed.
Sponsor:
Information provided by:
Vanderbilt University
ClinicalTrials.gov Identifier:
NCT00179218
First received: September 13, 2005
Last updated: July 8, 2009
Last verified: July 2009
  Purpose

The objective of this study is to determine how protein supplementation, with or without exercise, affects functional capacity, strength, body composition, and physical activity in hemodialysis patients.


Condition Intervention Phase
End Stage Renal Disease
Drug: nutritional supplementation
Behavioral: exercise
Phase 2

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Crossover Assignment
Masking: Open Label
Primary Purpose: Treatment
Official Title: The Effects of Resistance Exercise and Protein Supplementation in Hemodialysis Patients

Resource links provided by NLM:


Further study details as provided by Vanderbilt University:

Primary Outcome Measures:
  • increase in lean body mass [ Time Frame: 12 months ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • increase in physical functioning [ Time Frame: 12 months ] [ Designated as safety issue: No ]

Enrollment: 19
Study Start Date: April 2005
Study Completion Date: January 2007
Primary Completion Date: January 2007 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Active Comparator: 1
only protein supplementation
Drug: nutritional supplementation
oral administration of 2 cans of protein supplement (lactose-free formula that contains a total of 960 kilocalories: 132.8 kilocalories from protein, 412.8 kilocalories from carbohydrates, and 412.8 kilocalories from fat); every other day, 3 days per week, for 6 months
Active Comparator: 2
protein supplementation plus exercise
Drug: nutritional supplementation
oral administration of 2 cans of protein supplement (lactose-free formula that contains a total of 960 kilocalories: 132.8 kilocalories from protein, 412.8 kilocalories from carbohydrates, and 412.8 kilocalories from fat); every other day, 3 days per week, for 6 months
Behavioral: exercise
leg press exercise; every other day, 3 days per week, for 6 months

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • On hemodialysis for more than 3 months, on a thrice weekly hemodialysis program;
  • Adequately dialyzed (Kt/V ≥ 1.2).
  • Age ≥ 18 years old.

Exclusion Criteria:

  • Patients unable to perform exercise due to cardiovascular disease, osteoarthritis, etc., as determined by the PI and the primary physician of the subject.
  • Pregnant women.
  • Patients hospitalized within the last month prior to the study.
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00179218

Locations
United States, Tennessee
Vanderbilt University Medical Center
Nashville, Tennessee, United States, 37232
Sponsors and Collaborators
Vanderbilt University
Investigators
Principal Investigator: Alp Ikizler, MD Vanderbilt University
  More Information

No publications provided

Responsible Party: Alp Ikizler, MD, Vanderbilt University Medical Center
ClinicalTrials.gov Identifier: NCT00179218     History of Changes
Other Study ID Numbers: 50149, R01 DK 45604
Study First Received: September 13, 2005
Last Updated: July 8, 2009
Health Authority: United States: Institutional Review Board

Additional relevant MeSH terms:
Kidney Diseases
Kidney Failure, Chronic
Urologic Diseases
Renal Insufficiency, Chronic
Renal Insufficiency

ClinicalTrials.gov processed this record on April 16, 2014